Understanding early Rett Syndrome development
Early developmental mechanisms of Rett Syndrome
This research explores how Rett Syndrome begins in very early development to find new ways to help girls affected by this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11009544 on NIH RePORTER |
What this research studies
Rett Syndrome is a serious condition that mainly affects girls, caused by changes in a gene called MECP2. While we know this gene is important throughout life, recent findings suggest that the earliest signs of Rett Syndrome appear much sooner than previously thought. This project uses advanced stem cell technology, including patient-derived cells, to create tiny brain models called organoids. By observing these models with special microscopes and molecular tools, we aim to understand exactly how the MECP2 gene changes affect brain cell development and movement in the earliest stages of life.
Who could benefit from this research
Good fit: This foundational research is relevant to girls and women living with Rett Syndrome and their families, as it seeks to understand the very origins of the condition.
Not a fit: Patients not affected by Rett Syndrome would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could uncover critical early events in Rett Syndrome, leading to new strategies for early diagnosis and potential treatments.
How similar studies have performed: The researchers have previously shown that reduced MECP2 in patient-derived cells leads to specific issues in brain cell development, building on existing knowledge.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Sur, Mriganka — Massachusetts Institute of Technology
- Study coordinator: Sur, Mriganka
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.